# Brexpiprazole

## Rexulti 1mg

##### 

| 藥品代碼   | OREX                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|:-----------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症     | Schizophrenia.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 用法用量   | Initial， 1 mg orally once daily on days 1 through 4; titrate to 2 mg orally once daily on days 5 through 7， then to target dosage of 4 mg orally once daily beginning on day 8， based on response and tolerability; MAX 4 mg orally once daily; periodically reassess dosage and need for treatment.                                                                                                                                                                                                                                                                                                                                                         |
| 肝功能異常 | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 腎功能異常 | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 禁忌       | Hypersensitivity to brexpiprazole or any component of the product.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 副作用     | Common Endocrine metabolic: Hyperglycemia (9% to 10% )， Serum triglycerides raised (Short-term use， 5% to 13%; long-term use， 13% to 17% )， Weight increased (Short-term use， 2% to 11%; long-term use， 20% to 30% ) Neurologic: Akathisia ( 4% to 14% )， Extrapyramidal movements， Excluding akathisia (5% to 6% )， Headache (4% to 9% ) Serious Cardiovascular: Cerebrovascular accident， Orthostatic hypotension ( 0.1% to 0.4% )， Syncope (0.1% )， Transient ischemic attack Endocrine metabolic: Diabetic ketoacidosis Hematologic: Agranulocytosis Neurologic: Seizure Psychiatric: At risk for suicide Other: Neuroleptic malignant syndrome |
| 孕期建議   | Uknown 沒有資料                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 哺乳期建議 | Unknown 沒有資料                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |

